Indefinite Delivery Contract FA302021D0003
- Not listed
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency, with an ultimate completion date of September 30, 2028, and a ceiling value of approximately $6.0 million. The contract supports the supply of reagents, consumables, training, and maintenance services for a government-owned Roche Diagnostic Total Laboratory Automation system located at Madigan Army Medical Center. The contracted system comprises multiple Cobas Pro analytical...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Air Force Academy, a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and related medical products and services. The BPA, with a ceiling value of $950,000, is for the provision of chemistry analyzer tests on a cost per reportable result basis for three military treatment facilities: the 10th Medical Group, 21st Medical Group, and Evans Army Community Hospital. The...
- The Defense Health Agency has awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation (UEI: JDMDFEZBYH36) with a ceiling value of $606,000 for the provision of chemistry analyzer equipment and associated reagents on a cost-per-reportable-result basis. The contract, effective from October 1, 2025, through March 31, 2027, establishes a pricing mechanism that ties reimbursement directly to clinical testing output, enabling efficient procurement of diagnostic laboratory...
- This series of Blanket Purchase Agreement (BPA) awards to Roche Diagnostics Corporation provide the U.S. Department of Defense's Defense Health Agency (DHA) and Air Force Life Cycle Management Center (AFLCMC) with critical medical equipment, reagents, and consumables to support laboratory operations at military treatment facilities and the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory. The BPA awards, issued against Roche's existing General Services Administration...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The BPA and associated task orders provide the USAFSAM Epidemiology Laboratory with Roche's COVID-19 testing equipment, including automated molecular testing platforms, as well as associated kits, reagents, and...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory reagents, was awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the Defense Health Agency on September 23, 2022, with a ceiling value of $6.5 million and an ultimate completion date of September 22, 2027. The contract covers Roche Diagnostics Laboratory Library Preparation Kits and related consumable laboratory test and quantification materials. The primary places of...
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency with a ceiling value of $215,748.90, effective from October 1, 2025, through September 30, 2028. The contract, issued without set-aside designation, provides blood gas reagents, supplies, maintenance, and training services for Madigan Army Medical Center in Tacoma, Washington. This indefinite delivery vehicle serves as the parent contract mechanism enabling the government to issue...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, holds a General Services Administration (GSA) Federal Supply Schedule contract (FSS-66-III) for Critical Analyzers, Laboratory, awarded by Veterans Integrated Service Network 12 with a ceiling value of $700 million and an ultimate completion date of May 14, 2026. The master contract encompasses a comprehensive range of clinical laboratory analyzer equipment, reagents, supplies, and...
- Roche Diagnostics Corporation has been awarded a blanket purchase agreement (BPA) by the Defense Health Agency to provide various medical diagnostic products and services. The BPA utilizes firm fixed price calls issued against it to procure items such as COBAS assays, laboratory equipment and supplies, and cardiopulmonary resuscitation testing. These products and services support the Agency's global network of medical facilities and aid in diagnostic testing, medical research, and healthcare...
- Roche Diagnostics Corporation has been awarded an indefinite delivery contract by the Department of the Army Medical Command to provide immunochemistry testing services. The single award contract has a potential value of $16.6M and period of performance through September 2023. Under the contract vehicle, Roche has received multiple delivery orders to conduct clinical chemistry and immunoassay testing at its facility in Castleton, Indiana for various Army medical treatment facilities. Orders have...
- FA302021D0003Indefinite Delivery Contract
- 6Federal Contract Awards
Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Air Education and Training Command (AETC), a defense agency within the Department of the Air Force, with an ultimate completion date of March 31, 2026 and a ceiling value of $1,450,000. The contract, awarded on April 1, 2021, provides COBAS 6000 chemical analyzers, reagents, and test kits to support military treatment facilities over a five-year ordering period on a firm fixed-price basis. No set-aside designation was utilized for this award, indicating open competition in the federal marketplace. The primary place of performance is Sheppard Air Force Base in Texas, where the contractor delivers laboratory diagnostic equipment and consumables in accordance with the Performance Work Statement and contract specifications. Five delivery orders have been issued under this Indefinite Delivery Contract between April 2021 and October 2024, with cumulative values totaling approximately $610,338 against the contract ceiling. Each delivery order maintains firm fixed-price pricing and specifies Sheppard Air Force Base as the place of performance. The delivery orders demonstrate consistent annual procurement patterns, with awards issued each October (fiscal year transition) to provide continued supply of COBAS 6000 chemical analyzer reagents and test kits necessary for clinical laboratory operations. These delivery orders enable AETC to efficiently acquire essential diagnostic testing capabilities and supplies for military medical treatment facilities without requiring individual competitive solicitations, while Roche Diagnostics, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, maintains a significant presence across federal healthcare agencies including the Department of Veterans Affairs and Defense Health Agency through multiple similar indefinite delivery vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 9/30/25 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 8/3/23 | |
| Not listed | Not listed | $0 | 4/1/21 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order FA302021D0003-FA302021F0037 | Roche Diagnostics Corporation | $68.5k | 4/1/21 | 9/30/21 | 4/1/21 | |
Delivery Order FA302021D0003-FA302026F0020 | Roche Diagnostics Corporation | $137.1k | 10/1/25 | 9/30/26 | 10/1/25 | |
Delivery Order FA302021D0003-FA302022F0019 | Roche Diagnostics Corporation | $114.7k | 10/1/21 | 9/30/22 | 11/7/24 | |
Delivery Order FA302021D0003-FA302025F0021 | Roche Diagnostics Corporation | $137.1k | 10/1/24 | 9/30/25 | 12/26/24 | |
Delivery Order FA302021D0003-FA302023F0294 | Roche Diagnostics Corporation | $110.9k | 10/1/23 | 9/30/24 | 2/18/25 |